Neonatal (0 to 28 days of life) mortality represents about 70% of infant mortality in Brazil, an indicator of living conditions and health of the population. Birth weight < 2,500 g is pointed out as the most influential factor in determining neonatal morbidity and mortality. The fetal growth is regulated by genetic, environmental, hormonal, nutritional, and placental factors (
1).
IGF2 and
H19 genes are of special interest, since in addition to their reciprocal imprinting patterns, they are closely linked on chromosome 11 in humans and are strong candidate genes for influencing birth weight variation (
2). The human
H19 is an untranslated gene that lies within 200 kb downstream of the paternally expressed allele (
3). The maternally expressed
H19 gene itself does not encode a protein, but the RNA has growth potentially suppressing functions (
4) through inhibiting translation of IGF2 RNA (
5).
IGF2 appears to be an important growth factor and low expression of its gene might be associated with intrauterine fetal life damaging resulting in low birth weight (LW) of newborn and may predispose the individual to chronic diseases in post-natal life such as obesity and hypertension (
6). Studies have shown an association between birth weight with polymorphisms of
IGF2 and
H19 genes (
7).